By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Horizon Discovery today announced a collaboration with Promega to develop next-generation predictive human disease models.

The partnership, it said, centers on delivering "endogenous gene reporting capabilities in the form of Promega's luciferase and HaloTag reporter technologies" combined with Horizon Discovery's homologous recombination-based precision genome editing technology called rAAV Genesis.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: transcript patterns in drug-resistant cancer cells, function of high-altitude adaption gene, and more.

Monitoring gene expression changes could help sniff out athletes using performance-enhancing drugs, New Scientist says.

The University of Southern California lodges a cross-complaint in its legal dispute with the University of California, San Diego, over a large Alzheimer's disease project.

In PLOS this week: gene fusion in premature ovarian failure, population patterns in the Franciscana dolphin, and more.